Reuters logo
BRIEF-Innovation Pharmaceuticals opens new clinical site for novel p53 drug candidate in Phase 2 ovarian cancer trial
2017年9月14日 / 中午11点40分 / 5 天前

BRIEF-Innovation Pharmaceuticals opens new clinical site for novel p53 drug candidate in Phase 2 ovarian cancer trial

Sept 14 (Reuters) - Innovation Pharmaceuticals Inc

* Innovation Pharmaceuticals opens new clinical site for novel p53 drug candidate in Phase 2 ovarian cancer trial Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below